Clinical research that tallies the number of withdrawal symptoms (a symptom‑count metric like DESS) can understate how impairing those symptoms are because it treats all symptoms as equal and does not measure severity or functional impact. When high‑visibility meta‑analyses rely on such counts, they risk producing modest statistical effects that are misread as clinically trivial.
— This matters because it affects prescribing guidance, patient consent, and whether the public or clinicians take antidepressant withdrawal seriously.
2026.03.05
100% relevant
The JAMA Psychiatry meta‑analysis (Kalfas et al.) used the 43‑item DESS scale; the article highlights SMD 0.31 (= ~1 more DESS symptom) and notes DESS does not grade severity, directly exemplifying the issue.
← Back to All Ideas